Identification of an FGF-regulated signaling center in the Groove of Ranvier that controls longitudinal bone growth.
Identification of an FGF-regulated signaling center in the Groove of Ranvier that controls longitudinal bone growth.
批准号:
10667798
负责人:
David M Ornitz
金额:
$20.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2025-05-31
关键词:
AffectAllelesAnatomyApplications GrantsBone GrowthCell LineageCell SeparationCell physiologyCell surfaceCellsCharacteristicsChildChildhoodChondrocytesChondrogenesisClinicalDataDevelopmentDistalDoxycyclineDwarfismEmbryoEmbryonic DevelopmentEngineeringEpiphysial cartilageFGF9 geneFGFR1 geneFGFR3 geneFeedbackFemurFibroblast Growth FactorFibroblast Growth Factor ReceptorsFoundationsFractureFutureGeneticGrowthGrowth FactorHealthHistologicImpairmentIn Situ HybridizationKnowledgeLabelLigandsLinkLocationMusOsteoblastsOsteogenesisPathogenesisPhenotypePhysiologicalPopulationPregnancyProliferatingPropertyReceptor SignalingRegulationSignal TransductionSiteSkeletal DevelopmentSortingStromal CellsStructureTherapeuticTissuesTomatoesTransgenesVascular blood supplybiomarker identificationbonecapsuleembryo cellgenetic signatureinsightinterestpostnatalpreservationpreventsingle cell mRNA sequencingskeletal stem celltool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Growing bones contain a circumferential anatomical structure called the groove of Ranvier (GOR) that may
contain skeletal stem cells and signaling cells critical to skeletal development. Clinically, the GOR is important
as pediatric fractures involving the GOR (Salter-Harris type II) often affect longitudinal bone growth. However,
the identity and functional properties of cells within the GOR that regulate longitudinal bone growth are not
known. Our preliminary data suggest that Fibroblast Growth Factor Receptors (FGFRs) within the GOR
contribute to a “signaling center” that regulates adjacent growth plate chondrocytes and longitudinal bone growth.
This observation establishes a functional link between cells in the GOR and the growth plate and has implications
for the pathogenesis of pediatric physeal fractures. We refer to these poorly defined cells as the “GOR signaling
center”.
Conditional inactivation of Fgfr1 and Fgfr2 with the Osx-Cre transgene (Osx-Cre, DCKO mice) results in
decreased longitudinal bone growth in postnatal mice. Through an unknown feedback mechanism, this
inactivation also results in increased Fgf9 expression in the fibrous capsule and perichondrium, which is in close
proximity to the GOR. Experimentally, we showed that expression of FGF9 in the perichondrium can activate
FGFR3 in adjacent proliferating chondrocytes to suppress chondrogenesis.
By regulating the expression of Osx-Cre, we show that Cre must be active during embryonic development
to elicit this postnatal growth phenotype. Significantly, embryonic, but not postnatal, expression of Osx-Cre
specifically targets the GOR. These data functionally define the region encompassing the GOR as the location
of a critical FGFR1/2 signaling center by showing that inactivation of Fgfr1/2 in an embryonic cell lineage that
gives rise to the GOR, rather than in definitive osteoblasts, is responsible for the dramatic reduction in bone
growth observed in Osx-Cre, DCKO mice.
In specific aim 1, we will use lineage tracing to differentially label the GOR and single cell mRNA sequencing
to identify cell sub-populations within the GOR that have signaling center and/or skeletal stem cell properties.
Identification of selective markers for these cell sub-populations will be used to reveal their location relative to
the anatomical GOR. In specific aim 2, we will characterize the signaling properties of GOR cells for their ability
to regulate osteogenesis and chondrogenesis. The studies proposed here will identify unique features of GOR
cells as a potential cell signaling center with the unique ability to regulate adjacent growth plate tissue. These
studies will provide mechanistic insight into why a large percentage of pediatric physeal fractures result in growth
arrest despite theoretically preserving the proliferating chondrocytes and their intact blood supply. These studies
will provide new genetic tools to study the GOR in future grant proposals and potential therapeutic insight that
could be used to prevent growth arrest associated with physeal fractures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Osteocyte Survival by Fibroblast Growth Factor Signaling Pathways
-
批准号:10391803
-
项目类别:
-
资助金额:$52.41万
-
财政年份:2022
-
负责人:David M Ornitz
-
依托单位:
LTBP2 regulation of fibrotic lung damage
-
批准号:10633230
-
项目类别:
-
资助金额:$19.46万
-
财政年份:2022
-
负责人:David M Ornitz
-
依托单位:
LTBP2 regulation of fibrotic lung damage
-
批准号:10526774
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2022
-
负责人:David M Ornitz
-
依托单位:
Regulation of Osteocyte Survival by Fibroblast Growth Factor Signaling Pathways
-
批准号:10577758
-
项目类别:
-
资助金额:$52.41万
-
财政年份:2022
-
负责人:David M Ornitz
-
依托单位:
FGF18 regulation of postnatal lung development
-
批准号:10703208
-
项目类别:
-
资助金额:$62.51万
-
财政年份:2020
-
负责人:David M Ornitz
-
依托单位:
FGF18 regulation of postnatal lung development
-
批准号:10444913
-
项目类别:
-
资助金额:$62.51万
-
财政年份:2020
-
负责人:David M Ornitz
-
依托单位:
FGF18 regulation of postnatal lung development
-
批准号:10210438
-
项目类别:
-
资助金额:$62.51万
-
财政年份:2020
-
负责人:David M Ornitz
-
依托单位:
Signaling mechanisms and mouse models for insulin-mediated pseudoacromegaly
-
批准号:9764863
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2019
-
负责人:David M Ornitz
-
依托单位:
FGF9 REGULATION OF LUNG DEVELOPMENT AND PATHOGENESIS OF PLEUROPULMONARY BLASTOMA
-
批准号:8704993
-
项目类别:
-
资助金额:$49.76万
-
财政年份:2012
-
负责人:David M Ornitz
-
依托单位:
FGF9 REGULATION OF LUNG DEVELOPMENT AND PATHOGENESIS OF PLEUROPULMONARY BLASTOMA
-
批准号:8535194
-
项目类别:
-
资助金额:$48.34万
-
财政年份:2012
-
负责人:David M Ornitz
-
依托单位:
FGF9 REGULATION OF LUNG DEVELOPMENT AND PATHOGENESIS OF PLEUROPULMONARY BLASTOMA
-
批准号:8371642
-
项目类别:
-
资助金额:$52.07万
-
财政年份:2012
-
负责人:David M Ornitz
-
依托单位:
FIBROBLAST GROWTH FACTOR SIGNALING IN HEART INJURY AND REPAIR
-
批准号:8402608
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2011
-
负责人:David M Ornitz
-
依托单位:
FIBROBLAST GROWTH FACTOR SIGNALING IN HEART INJURY AND REPAIR
-
批准号:8782498
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2011
-
负责人:David M Ornitz
-
依托单位:
FIBROBLAST GROWTH FACTOR SIGNALING IN HEART INJURY AND REPAIR
-
批准号:8600984
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2011
-
负责人:David M Ornitz
-
依托单位:
FIBROBLAST GROWTH FACTOR SIGNALING IN HEART INJURY AND REPAIR
-
批准号:8207203
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:David M Ornitz
-
依托单位:
FIBROBLAST GROWTH FACTOR SIGNALING IN HEART INJURY AND REPAIR
-
批准号:8024992
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:David M Ornitz
-
依托单位:
Mouse Genetic Models
-
批准号:8246484
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2011
-
负责人:David M Ornitz
-
依托单位:
Cancer and Developmental Biology
-
批准号:8181174
-
项目类别:
-
资助金额:$0.79万
-
财政年份:2010
-
负责人:David M Ornitz
-
依托单位:
Genetic Mouse Models
-
批准号:9031064
-
项目类别:
-
资助金额:$12.43万
-
财政年份:2009
-
负责人:David M Ornitz
-
依托单位:
TOOLS TO EXPLORE FHF FUNCTION AND SPINOCEREBELLAR ATAXIA 27
-
批准号:7566025
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2008
-
负责人:David M Ornitz
-
依托单位:
海外基金